Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia von Manolova, Vania, Nyffenegger, Naja, Flace, Anna, Altermatt, Patrick, Varol, Ahmet, Doucerain, Cédric, Sundstrom, Hanna, Dürrenberger, Franz

Volltext

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease von Nyffenegger, Naja, Zennadi, Rahima, Kalleda, Natarajaswamy, Flace, Anna, Ingoglia, Giada, Buzzi, Raphael M., Doucerain, Cédric, Buehler, Paul W., Schaer, Dominik J., Dürrenberger, Franz, Manolova, Vania

Volltext

Oral ferroportin inhibitor VIT‐2763: First‐in‐human, phase 1 study in healthy volunteers von Richard, Frank, Lier, Jan Jaap, Roubert, Bernard, Haboubi, Teba, Göhring, Udo‐Michael, Dürrenberger, Franz

Volltext

Iron is a modifier of the phenotypes of JAK2-mutant myeloproliferative neoplasms von Stetka, Jan, Usart, Marc, Kubovcakova, Lucia, Rai, Shivam, Rao, Tata Nageswara, Sutter, Joshua, Hao-Shen, Hui, Dirnhofer, Stefan, Geier, Florian, Bader, Michael S., Passweg, Jakob R., Manolova, Vania, Dürrenberger, Franz, Ahmed, Nouraiz, Schroeder, Timm, Ganz, Tomas, Nemeth, Elizabeta, Silvestri, Laura, Nai, Antonella, Camaschella, Clara, Skoda, Radek C.

Volltext

Structures of ferroportin in complex with its specific inhibitor vamifeport von Lehmann, Elena Farah, Liziczai, Márton, Drożdżyk, Katarzyna, Altermatt, Patrick, Langini, Cassiano, Manolova, Vania, Sundstrom, Hanna, Dürrenberger, Franz, Dutzler, Raimund, Manatschal, Cristina

Volltext

Image-based quantification of mitochondrial iron uptake via Mitoferrin-2 von Polesel, Marcello, Wildschut, Mattheus H.E., Doucerain, Cédric, Kuhn, Michael, Flace, Anna, Sá Zanetti, Leandro, Steck, Anna-Lena, Wilhelm, Maria, Ingles-Prieto, Alvaro, Wiedmer, Tabea, Superti-Furga, Giulio, Manolova, Vania, Dürrenberger, Franz

Volltext

An Overview of Cell-Based Assay Platforms for the Solute Carrier Family of Transporters von Dvorak, Vojtech, Wiedmer, Tabea, Ingles-Prieto, Alvaro, Altermatt, Patrick, Batoulis, Helena, Bärenz, Felix, Bender, Eckhard, Digles, Daniela, Dürrenberger, Franz, Heitman, Laura H, IJzerman, Adriaan P, Kell, Douglas B, Kickinger, Stefanie, Körzö, Daniel, Leippe, Philipp, Licher, Thomas, Manolova, Vania, Rizzetto, Riccardo, Sassone, Francesca, Scarabottolo, Lia, Schlessinger, Avner, Schneider, Vanessa, Sijben, Hubert J, Steck, Anna-Lena, Sundström, Hanna, Tremolada, Sara, Wilhelm, Maria, Wright Muelas, Marina, Zindel, Diana, Steppan, Claire M, Superti-Furga, Giulio

Volltext

Identification of a cAMP-dependent protein kinase catalytic subunit required for virulence and morphogenesis in Ustilago maydis von Durrenberger, F. (University of British Columbia, Vancouver, BC, Canada.), Wong, K, Kronstad, J.W

Volltext

The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia von Nyffenegger, Naja, Flace, Anna, Doucerain, Cédric, Dürrenberger, Franz, Manolova, Vania

Volltext

Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions von Kalleda, Natarajaswamy, Flace, Anna, Altermatt, Patrick, Ingoglia, Giada, Doucerain, Cédric, Nyffenegger, Naja, Dürrenberger, Franz, Manolova, Vania

Volltext

Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of [beta]-thalassemia von Manolova, Vania, Nyffenegger, Naja, Flace, Anna, Altermatt, Patrick, Varol, Ahmet, Doucerain, Cedric, Sundstrom, Hanna, Durrenberger, Franz

Volltext

The oral ferroportin inhibitor vamifeport prevents liver iron overload in a mouse model of hemochromatosis von Nyffenegger, Naja, Flace, Anna, Varol, Ahmet, Altermatt, Patrick, Doucerain, Cédric, Sundstrom, Hanna, Dürrenberger, Franz, Manolova, Vania

Volltext

Combination Therapy with Luspatercept and the Ferroportin Inhibitor Vamifeport Is Superior to Either Drug Alone in Improving Anemia and Reducing Myeloid Skewing in MDS von Antypiuk, Ada, Vance, Steven, Dürrenberger, Franz, Manolova, Vania, Vinchi, Francesca

Volltext

Functional Characterization of Fluorescent Hepcidin von Dürrenberger, Franz, Abbate, Vincenzo, Ma, Yongmin, Arno, Maria C, Jaiash, Dareen, Parmar, Archna, Marshall, Victoria, Latunde-Dada, Gladys O, Zimmermann, Tina, Senn, David, Altermatt, Patrick, Manolova, Vania, Hider, Robert C, Bansal, Sukhvinder S

Volltext

3207 – GENETIC IRON OVERLOAD EXACERBATES AND PHARMACOLOGICAL IRON RESTRICTION IMPROVES MDS PATHOPHYSIOLOGY IN PRECLINICAL STUDIES von Vinchi, Francesca, Antypiuk, Ada, Vance, S.Zebulon, Dürrenberger, Franz, Manolova, Vania

Volltext

Genetic Iron Overload Aggravates and Pharmacological Iron Restriction Improves MDS Pathophysiology in a Preclinical Mouse Model von Vance, S. Zebulon, Antypiuk, Ada, Sharma, Richa, Dürrenberger, Franz, Manolova, Vania, Vinchi, Francesca

Volltext

Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of b-thalassemia with blood transfusions von Kalleda, Natarajaswamy, Flace, Anna, Altermatt, Patrick, Ingoglia, Giada, Doucerain, Cédric, Nyffenegger, Naja, Dürrenberger, Franz, Manolova, Vania

Volltext

The oral ferroportin inhibitor vamifeport improved hemodynamics in a mouse model of sickle cell disease von Nyffenegger, Naja, Zennadi, Rahima, Kalleda, Natarajaswamy, Flace, Anna, Ingoglia, Giada, Buzzi, Raphael Matthias, Doucerain, Cédric, Buehler, Paul W, Schaer, Dominik J, Dürrenberger, Franz, Manolova, Vania

Volltext

The RESOLUTE consortium: unlocking SLC transporters for drug discovery von Superti-Furga, Giulio, Lackner, Daniel, Wiedmer, Tabea, Ingles-Prieto, Alvaro, Barbosa, Barbara, Girardi, Enrico, Goldmann, Ulrich, Gürtl, Bettina, Klavins, Kristaps, Klimek, Christoph, Lindinger, Sabrina, Liñeiro-Retes, Eva, Müller, André C., Onstein, Svenja, Redinger, Gregor, Reil, Daniela, Sedlyarov, Vitaly, Wolf, Gernot, Crawford, Matthew, Everley, Robert, Hepworth, David, Noell, Stephen, Piotrowski, Mary, Stanton, Robert, Zhang, Hui, Corallino, Salvatore, Faedo, Andrea, Insidioso, Maria, Maresca, Giovanna, Redaelli, Loredana, Sassone, Francesca, Scarabottolo, Lia, Stucchi, Michela, Tarroni, Paola, Tremolada, Sara, Batoulis, Helena, Becker, Andreas, Bender, Eckhard, Chang, Yung-Ning, Ehrmann, Alexander, Müller-Fahrnow, Anke, Pütter, Vera, Zindel, Diana, Hamilton, Bradford, Lenter, Martin, Santacruz, Diana, Viollet, Coralie, Whitehurst, Charles, Johnsson, Kai, Leippe, Philipp, Baumgarten, Birgit, Chang, Lena, Ibig, Yvonne, Pfeifer, Martin, Reinhardt, Jürgen, Schönbett, Julian, Selzer, Paul, Seuwen, Klaus, Bettembourg, Charles, Biton, Bruno, Czech, Jörg, de Foucauld, Hélène, Didier, Michel, Licher, Thomas, Mikol, Vincent, Pommereau, Antje, Puech, Frédéric, Yaligara, Veeranagouda, Edwards, Aled, Bongers, Brandon J., Heitman, Laura H., IJzerman, Ad P., Sijben, Huub J., van Westen, Gerard J.P., Grixti, Justine, Kell, Douglas B., Mughal, Farah, Swainston, Neil, Wright-Muelas, Marina, Burgess-Brown, Nicola, Carpenter, Liz, Dürr, Katharina, Hansen, Jesper, Scacioc, Andreea, Colas, Claire, Digles, Daniela, Ecker, Gerhard, Füzi, Barbara, Gamsjäger, Viktoria, Grandits, Melanie, Martini, Riccardo, Troger, Florentina, Altermatt, Patrick, Doucerain, Cédric, Dürrenberger, Franz, Manolova, Vania, Steck, Anna-Lena, Sundström, Hanna, Wilhelm, Maria, Steppan, Claire M.

Volltext

FC014: Target Deconvolution from Phenotypic Screens—Identification of Ataxia Telangiectasia Mutated as a Potential Therapeutic Target for Podocyte Protection von Stumm, Jürgen, Schmidt, Antje, Gehrmann, Wiebke, Feist, Maren, Fritsch, Rüdiger, Kottig, Karsten, Dürrenberger, Franz, Krauser, Joel, Moreno Quinn, Carol, Radresa, Olivier, Stegmann, Christian, Andag, Uwe

Volltext